BUSAN, South Korea -Thursday 13 September 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Busan Metropolitan City has announced that it will host the 23rd Busan International Film Festival and G-STAR 2018.

The 23rd Busan International Film Festival will feature 323 movies on 30 screens from October 4th to 13th, and the nation’s best gaming expo, G-Star 2018 will be held at BEXCO in Busan from November 15th to 18th, 2018.

During the 23rd Busan International Film Festival, 323 movies from 79 countries will be screened on 30 screens in five theaters, including the Busan Cinema Center, CGV Centum City, Lotte Cinema Centum City and Megabox Haeundae.

Films include 115 World Premiere films (85 long films, 30 short films) and 25 International Premiere films (24 long films, 1 short).

The opening film chosen for this year’s festival is “Beautiful Days” directed by Yun Jero and the selected closing film is “Master Z: The Ip Man Legacy ... Read more »

 • OTIVACTO study reported improvements in both physical functioning and general condition in people living with COPD receiving Spiolto® (tiotropium/olodaterol) Respimat® therapy1 • 4 out of 5 patients reported high satisfaction with their Respimat® inhaler and tiotropium/olodaterol treatment overall1 • Data presented at European Respiratory Society International Congress 20181

For media excluding the United States of America, Canada and the United Kingdom

INGELHEIM, Germany-Monday 17 September 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease (COPD) patients treated with Spiolto® (tiotropium/olodaterol) Respimat®, which were presented today at the European Respiratory Society (ERS) International Congress 2018 in Paris, France.1 Patients in the study reported both i ... Read more »

LUXEMBOURG-Wednesday 12 September 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- KNEIP continues to underline its digital transformation in the funds management sector with more industry experts joining their team.

Over the last 2 years, KNEIP has transformed its business into a new digital era. Leading this vision is the Founder and Chairman, Bob Kneip, who will continue to support the management and strategy of KNEIP. Having assisted KNEIP with the business transformation and readying KNEIP to be global and digital, current CEO Lee Godfrey will move into a newly formed role as Chief Corporate Development Officer, to truly take our digital business global and into new vertical markets.

Neil Ward will become CEO, activating the new business strategy and empowering a strongly forecasted growth. Neil brings a wealth of experience, having previously served as SVP and GM of Global Business Operations at Skype.

Furthermore, Sigrid Nygaard Johansen will be joining K ... Read more »

 From AIoT, Blockchain, Gene Editing, Cell Therapy, to Immune-Oncology, Med x Tech Summit Asia (MEDTEX) brings over 30 cross-industry global key opinion leaders to Taipei.

TAIPEI, Taiwan-Monday 17 September 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in global healthcare technology and provider. On November 29 - 30, MEDTEX will focus on 3 key trends: Intelligent Healthcare, Next-generation Biotherapeutics, and Bio-Innovation. Jointed by over 30 world-renowned experts.

At CEO forum, leaders from Merck, Teva, Hitachi, and Nvidia will set the tune of MEDTEX by pushing the boundaries of healthcare through cross-industry collaborations and addressing the upcoming opportunities and challenges.

Follows by Digital Healthcare forum, MEDTEX welcomes Microsoft, Google, Mayo Clinic, and Extensia to discuss topics on how healthcare can leverage AI, AIoT, clo ... Read more »

INGELHEIM, Germany -Thursday 13 September 2018 [ AETOS Wire ]

   • Boehringer Ingelheim exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics
   • ViraTherapeutics will operate in Innsbruck, Austria as a distinct unit of Boehringer Ingelheim’s Discovery Research organization, maintaining its innovative biotech heritage and close connections to the Medical University of Innsbruck and the regional scientific community
   • Acquisition strengthens Boehringer Ingelheim’s commitment to research and development of viral-based immuno-oncology treatment options aimed at transforming the lives of patients

(BUSINESS WIRE)-- Boehringer Ingelheim today announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies. ViraTherapeutics developed the lead candidate VSV-GP (Vesicular Stomat ... Read more »